1. Marketing Aspects of Company-Sponsored Postmarketing Surveillance Studies

   • Myles D. B. Stephens

   Leading Article 26 October 2012 Pages: 1 - 8

2. The Withdrawal of Temafloxacin

   • Roger G. Finch

   Leading Article 26 October 2012 Pages: 9 - 11

3. Theophylline

   • Shuaib S. M. Nasser
   • P. John Rees

   Commentary 26 October 2012 Pages: 12 - 18

4. Comparative Tolerability Profiles of Thrombolytic Agents

   • Kam S. Woo
   • Harvey D. White

   Review Article 26 October 2012 Pages: 19 - 29

5. Drug Interactions of Clinical Significance with Opioid Analgesics

   • Philip M. Maurer
   • Richard R. Bartkowski

   Review Article 26 October 2012 Pages: 30 - 48

6. Risk-Benefit Assessment of Nicotine Preparations in Smoking Cessation

   • John R. Hughes

   Review Article 26 October 2012 Pages: 49 - 56

7. Effects of Exogenous Lipids on Cancer and Cancer Chemotherapy

   • C. Patrick Burns
   • Brett A. Wagner

   Review Article 26 October 2012 Pages: 57 - 68

8. An International Comparison of Case Definition of Severe Adverse Cutaneous Reactions to Medicines

   • Robert S. Stern
   • Edith Albengres
   • Bengt-Erik Wiholm

   Original Research Article 26 October 2012 Pages: 69 - 77

9. Acute Amitriptyline Withdrawal and Hyponatraemia

   • Paul Davison
   • James Wardrope

   Case Report 26 October 2012 Pages: 78 - 80

10. Carbamazepine Overdose

    • John F. Seymour

    Case Report 26 October 2012 Pages: 81 - 88